Roche announces FDA approval of label expansion into biliary tract cancer - Markets Insider

Retrieved on: 2024-11-25 18:36:37

Tags for this article:

Click the tags to see associated articles and topics

Roche announces FDA approval of label expansion into biliary tract cancer - Markets Insider. View article details on hiswai:

Excerpt

Roche (RHHBY) announced the FDA approval of a label expansion into biliary tract cancer, or BTC, for the Pathway anti-HER2/neu Rabbit Monoclonal.

Article found on: markets.businessinsider.com